# Shunya Ikeda

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/shunya-ikeda/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,701 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 36 |
| i10-index | 88 |
| Last Known Institution | Hiroshima University |
| OpenAlex ID | https://openalex.org/A5064794823 |
| ORCID iD | 0000-0002-1866-2155 |
| Works | 300 |

## Researcher papers

- [The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)](https://scholariq.org/papers/the-japanese-society-of-hypertension-guidelines-for-the-management-of/)
- [What has made the population of Japan healthy?](https://scholariq.org/papers/what-has-made-the-population-of-japan-healthy/)
- [Estimating an EQ‐5D population value set: the case of Japan](https://scholariq.org/papers/estimating-an-eq-5d-population-value-set-the-case-of-japan/)
- [Development of a Database of Health Insurance Claims: Standardization of Disease Classifications and Anonymous Record Linkage](https://scholariq.org/papers/development-of-a-database-of-health-insurance-claims-standardization-of-disease/)
- [Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D](https://scholariq.org/papers/japanese-population-norms-for-preference-based-measures-eq-5d-3l-eq-5d-5l-and-sf/)
- [Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan](https://scholariq.org/papers/comparison-of-value-set-based-on-dce-and-or-tto-data-scoring-for-eq-5d-5l-health/)
- [Adult Mortality Attributable to Preventable Risk Factors for Non-Communicable Diseases and Injuries in Japan: A Comparative Risk Assessment](https://scholariq.org/papers/adult-mortality-attributable-to-preventable-risk-factors-for-non-communicable/)
- [Developing a Japanese version of the EQ-5D-5L value set](https://scholariq.org/papers/developing-a-japanese-version-of-the-eq-5d-5l-value-set/)
- [Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan](https://scholariq.org/papers/development-of-an-official-guideline-for-the-economic-evaluation-of-drugs/)
- [Measurement of HRQL Using EQ-5D in Patients with Type 2 Diabetes Mellitus in Japan](https://scholariq.org/papers/measurement-of-hrql-using-eq-5d-in-patients-with-type-2-diabetes-mellitus-in/)
- [Burden in caregivers of patients with schizophrenia, depression, dementia, and stroke in Japan: comparative analysis of quality of life, work productivity, and qualitative caregiving burden](https://scholariq.org/papers/burden-in-caregivers-of-patients-with-schizophrenia-depression-dementia-and/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Pharmacy and Medical Practices](https://scholariq.org/topics/pharmacy-and-medical-practices/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Economic and Environmental Valuation](https://scholariq.org/topics/economic-and-environmental-valuation/)

## Researcher university

- [Hiroshima University](https://scholariq.org/institutions/hiroshima-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.